Does intermittent fasting lower cholesterol? It is a question increasingly asked by people looking to improve their cardiovascular health through dietary changes. Intermittent fasting (IF) — which includes approaches such as the 16:8 method and the 5:2 diet — has been associated with modest improvements in lipid profiles, including reductions in LDL cholesterol and triglycerides. However, the evidence is still evolving, and many benefits appear closely linked to overall caloric reduction rather than fasting timing alone. This article explores what the clinical research shows, how different IF protocols compare, and when to seek medical advice about high cholesterol.

How Intermittent Fasting May Affect Cholesterol Levels

Intermittent fasting may lower cholesterol by triggering metabolic switching, which alters how the liver produces lipoproteins, potentially reducing LDL cholesterol and triglycerides whilst having variable effects on HDL.

Intermittent fasting (IF) refers to structured eating patterns that cycle between periods of fasting and eating. Rather than focusing on what you eat, it focuses on when you eat. Common approaches include the 16:8 method (fasting for 16 hours, eating within an 8-hour window) and the 5:2 diet (eating normally for five days and restricting calories significantly on two non-consecutive days).

From a physiological standpoint, intermittent fasting may influence cholesterol levels through several mechanisms. During fasting periods, the body shifts from using glucose as its primary fuel source to mobilising stored fat. This process — known as metabolic switching — may alter how the liver processes and produces lipoproteins, the particles that carry cholesterol through the bloodstream.

In human studies, fasting has been associated with:

• Reductions in triglyceride levels, possibly by decreasing the liver's production of very-low-density lipoprotein (VLDL)

• Modest reductions in LDL cholesterol (often referred to as 'bad' cholesterol), though the precise mechanism is not fully established and results vary between studies

• Variable effects on HDL cholesterol (often referred to as 'good' cholesterol) — some studies show modest increases, whilst others show little change

These effects are thought to be partly driven by reductions in insulin levels during fasting, which may reduce lipogenesis (fat production in the liver). However, it is important to note that many of the lipid benefits observed in trials appear to be largely mediated by weight loss and overall caloric restriction, rather than the timing of eating per se. Separating the direct effect of fasting from the benefits of eating less overall remains methodologically challenging.

In UK clinical practice, cholesterol is commonly assessed using a non-fasting lipid profile, with non-HDL cholesterol reported as a key marker alongside total cholesterol, LDL, HDL, and triglycerides. A fasting sample is generally only required when triglyceride levels are very high or when a more precise LDL calculation is needed.

What the Clinical Evidence Says

Clinical evidence suggests IF can modestly improve cholesterol levels, but benefits are largely comparable to continuous caloric restriction, and long-term cardiovascular outcome data remain insufficient.

The clinical evidence on whether intermittent fasting lowers cholesterol is promising but still evolving. Several randomised controlled trials and systematic reviews have examined the effect of IF on lipid profiles, with generally positive — though not universally consistent — findings.

A 2020 systematic review and meta-analysis published in Obesity Reviews (Harris et al.) found that intermittent fasting was associated with statistically significant reductions in total cholesterol, LDL cholesterol, and triglycerides in overweight and obese adults. HDL cholesterol showed modest improvements in some, but not all, studies reviewed. Importantly, many of these improvements were comparable to those seen with continuous caloric restriction, suggesting that the timing of eating may not confer additional lipid benefits beyond overall energy reduction.

It is also important to note that current evidence on IF is largely limited to short- to medium-term trials. Evidence for hard cardiovascular outcomes — such as reduction in heart attack or stroke rates — with intermittent fasting is currently insufficient, and longer-term randomised trials are needed before definitive conclusions can be drawn.

Some studies have raised nuanced concerns. A 2024 observational study presented at the American Heart Association's Scientific Sessions suggested that a time-restricted eating pattern (specifically an 8-hour eating window) was associated with a higher risk of cardiovascular mortality in certain populations. However, this study had significant methodological limitations, including reliance on self-reported dietary data collected over just two days, and it had not undergone full peer review at the time of reporting. The British Heart Foundation noted these limitations and advised against drawing firm conclusions from the findings. No causal link between short-term intermittent fasting and increased cardiovascular risk has been established based on current UK guidance.

Overall, the evidence suggests that intermittent fasting can modestly improve cholesterol levels, particularly in individuals who are overweight or have metabolic syndrome. However, results vary depending on the type of fasting protocol, individual metabolic health, dietary quality during eating windows, and duration of the intervention.

Types of Intermittent Fasting and Their Impact on Lipid Profiles

Different IF protocols vary in their lipid effects; alternate day fasting shows the largest LDL reductions, whilst time-restricted eating has more variable results, and diet quality during eating windows remains critical.

Not all intermittent fasting protocols are equal in their effects on cholesterol. The most widely studied approaches each carry slightly different implications for lipid health.

The 5:2 Diet This approach involves eating normally for five days and restricting intake to approximately 500–600 kcal on two non-consecutive days. It has been widely discussed in UK health media and is referenced in some NHS-affiliated resources. Studies suggest it can reduce LDL cholesterol and triglycerides, particularly when overall weekly caloric intake is reduced. It may be more sustainable for some individuals than daily fasting windows.

Time-Restricted Eating (TRE) — 16:8 or 14:10 This is currently the most researched form of IF. A 14:10 window (eating within 10 hours) may be more appropriate for older adults or those new to fasting. Evidence suggests TRE can reduce fasting triglycerides and total cholesterol, though effects on LDL and HDL are more variable. Some research suggests that aligning the eating window with earlier daylight hours may enhance metabolic benefits through circadian rhythm alignment, though this evidence is still emerging and not yet conclusive.

Alternate Day Fasting (ADF) This involves alternating between normal eating days and very-low-calorie days. ADF has shown some of the most significant reductions in LDL cholesterol and triglycerides in short-term trials, though adherence tends to be lower. Prolonged or complete fasting days should not be attempted without medical supervision, particularly in those with existing health conditions.

Regardless of the protocol chosen, the quality of food consumed during eating windows remains critically important. A diet high in saturated fats, ultra-processed foods, or refined carbohydrates during eating periods is likely to offset any lipid benefits gained from fasting intervals.

Important safety note: Intermittent fasting is not appropriate for everyone. You should seek medical advice before starting IF — and in some cases avoid it entirely — if you are:

• Pregnant or breastfeeding

• Under 18 years of age

• Underweight, or have a history of an eating disorder

• Living with type 1 diabetes

• Living with type 2 diabetes and taking insulin, sulfonylureas (such as gliclazide), or SGLT2 inhibitors (such as dapagliflozin or empagliflozin)

• Frail or managing significant comorbidities

The British Dietetic Association (BDA) provides a balanced overview of IF, including guidance on who should avoid it, in their Food Fact Sheet on Intermittent Fasting.

Other Lifestyle Factors That Influence Cholesterol

Cholesterol is shaped by diet composition, physical activity, smoking, alcohol, body weight, and sleep — reducing saturated fat and increasing soluble fibre are among the most evidence-based dietary strategies.

Intermittent fasting does not operate in isolation. Cholesterol levels are influenced by a wide range of lifestyle, dietary, and genetic factors, and it is important to consider these alongside any fasting regimen.

Diet composition remains one of the most significant modifiable factors. Reducing saturated fat intake — found in fatty meats, full-fat dairy, butter, and many processed foods — and replacing it with unsaturated fats from sources such as olive oil, oily fish, nuts, and avocados is well-evidenced to lower LDL cholesterol. Minimising trans fats (found in some processed and fried foods) is also recommended. Increasing soluble fibre from oats, pulses, and fruit can help reduce cholesterol absorption in the gut. UK dietary guidance suggests aiming for around 30 g of fibre per day as part of a healthy dietary pattern.

Physical activity plays an important independent role. Regular aerobic exercise — such as brisk walking, cycling, or swimming — has been shown to raise HDL cholesterol and reduce triglycerides. The UK Chief Medical Officers' physical activity guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, as reflected in NHS guidance.

Other relevant factors include:

• Smoking: Smoking lowers HDL cholesterol and damages blood vessel walls, compounding cardiovascular risk

• Alcohol: Excessive alcohol intake raises triglyceride levels; the NHS recommends no more than 14 units per week, spread across several days

• Body weight: Even modest weight loss of 5–10% of body weight can meaningfully improve lipid profiles

• Stress and sleep: Chronic stress and poor sleep quality have been associated with adverse changes in cholesterol metabolism, though the mechanisms are not fully understood

For individuals with familial hypercholesterolaemia (FH) — a genetic condition causing very high LDL levels — lifestyle changes alone are rarely sufficient, and medication such as statins is typically required alongside dietary measures, in line with NICE guideline CG71.

When to Seek Medical Advice About High Cholesterol

Speak to your GP if you are aged 40 or over and have not had a cholesterol check, have a family history of heart disease, or are considering IF with an existing health condition.

High cholesterol typically causes no symptoms, which is why it is often referred to as a 'silent' risk factor. Many people are unaware they have elevated cholesterol until it is detected through a routine blood test or following a cardiovascular event such as a heart attack or stroke.

If you experience chest pain, sudden severe headache, facial drooping, arm weakness, or difficulty speaking, call 999 immediately — these may be signs of a heart attack or stroke and require emergency care.

You should speak to your GP if:

• You have not had a cholesterol check and are aged 40 or over

• You have a family history of high cholesterol, heart disease, or stroke at a young age

• You have been told you have high cholesterol previously and are unsure whether it is being adequately managed

• You are considering starting intermittent fasting and have an existing health condition such as diabetes, kidney disease, or a history of eating disorders

• You experience unexplained symptoms such as chest pain, shortness of breath, or pain in the legs when walking, which may indicate cardiovascular complications

GPs can arrange a non-fasting lipid profile blood test, which measures total cholesterol, LDL, HDL, non-HDL cholesterol, and triglycerides. Non-HDL cholesterol is commonly used in UK practice as a key marker of cardiovascular risk. A fasting sample is generally only required when triglycerides are very high or in specific clinical circumstances. In England, NHS Health Checks are offered to adults aged 40–74 every five years and include cholesterol testing as standard.

If cholesterol levels are significantly elevated, or if your overall cardiovascular risk is assessed as high using tools such as QRISK3, your GP may recommend lifestyle changes, referral to a dietitian, or initiation of lipid-lowering medication. In line with NICE guideline NG238, a statin (typically atorvastatin 20 mg) is offered for primary prevention when the 10-year cardiovascular risk is 10% or greater, and may be considered after shared decision-making for those with a risk of 5–10%. If familial hypercholesterolaemia or very high triglycerides (for example, above 10 mmol/L) are suspected, referral to a specialist lipid clinic may be appropriate.

It is important not to delay seeking advice or to rely solely on dietary interventions such as intermittent fasting if your cholesterol levels are clinically significant.

NHS Guidance on Managing Cholesterol Through Diet

The NHS recommends reducing saturated fat, increasing unsaturated fats and soluble fibre, and eating oily fish twice weekly; intermittent fasting should complement, not replace, these established dietary principles.

The NHS provides clear, evidence-based dietary guidance for managing cholesterol, which aligns broadly with recommendations from NICE (National Institute for Health and Care Excellence) and the British Heart Foundation.

The NHS advises reducing intake of saturated fats, which raise LDL cholesterol. Key sources to limit include:

• Fatty cuts of meat and processed meats such as sausages and bacon

• Full-fat dairy products including butter, cream, and hard cheeses

• Coconut oil and palm oil

• Pastries, biscuits, and cakes made with hydrogenated or partially hydrogenated fats

In place of these, the NHS recommends increasing unsaturated fats from oily fish (such as salmon, mackerel, and sardines), nuts, seeds, and plant-based oils. Eating at least two portions of fish per week — one of which should be oily — is specifically recommended for cardiovascular health, in line with the NHS Eatwell Guide.

Soluble fibre is another key dietary component. Foods such as oats, barley, lentils, beans, and certain fruits (particularly apples and citrus) contain beta-glucan and pectin, which bind to cholesterol in the digestive tract and reduce its absorption. Consuming approximately 3 g of beta-glucan per day from oats or barley has been associated with modest LDL reductions.

Plant sterols and stanols, found in fortified foods such as certain margarines and yoghurts, have been shown to reduce LDL cholesterol by approximately 5–15% when consumed at around 2 g per day. However, it is important to note that NICE does not routinely recommend plant sterols or stanols for cardiovascular disease prevention in the general population. If used, they should be considered an adjunct to — not a substitute for — prescribed lipid-lowering therapy and broader dietary changes. They are not suitable for pregnant or breastfeeding women, or children under five.

Intermittent fasting can be a useful framework for some individuals to reduce overall caloric intake and improve metabolic health, but it should complement — not replace — these established dietary principles. Anyone considering significant dietary changes, particularly those with existing health conditions or who are taking medication, should seek personalised advice from their GP or a registered dietitian before making changes.

Frequently Asked Questions